Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients with Spinal Cord Injury

Rehabilitation

Standing/walking/mobility

Online since 22 April 2025, updated today

About this trial

This trial is enrolling 20 pediatric participants (3–14 years) with spinal cord injury to test the safety, usability and efficacy of the ATLAS 2030 robotic gait exoskeleton. An exoskeleton is an externally worn powered robotic device to assist movement. If included, participants will complete 10 robot-assisted walking training sessions under the supervision of a physical therapist. Final testing of safety and usability will be performed after 8 weeks.

Included participants

Gender

All

Age

3 - 14 years

Injury level

C1 - S5

Severity (AIS)?

Time since injury

All

Healthy volunteers

C1-S5

What’s involved

Type

Rehabilitation

Details

- Participants will complete 10 walking training sessions with the ATLAS 2030 robotic gait exoskeleton under the supervision of a physiotherapist. - An exoskeleton is an externally worn powered robotic device to assist movement. - Final testing of safety and usability will be performed after 8 weeks.

Potential benefits

Main benefits

Standing/walking/mobility

Additional benefits

Arm/hand function

General health

Pain

Skin health

Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

Wings for Life supports SCITrialsFinder

Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

Learn more

Back to results